Revance Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Revance Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2013 to Q3 2024.
  • Revance Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 105M shares, a 19.5% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 105M +17.1M +19.5% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 105M +16.9M +19.2% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 104M +20.4M +24.3% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 88M +5.58M +6.77% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 87.8M +5.53M +6.72% Sep 30, 2023 10-Q 2024-11-07
Q2 2023 87.9M +14.8M +20.3% Jun 30, 2023 10-Q 2024-08-08
Q1 2023 84M +12.3M +17.1% Mar 31, 2023 10-Q 2024-05-09
Q4 2022 82.4M +10.8M +15.1% Dec 31, 2022 10-K 2024-02-28
Q3 2022 82.3M +10.4M +14.5% Sep 30, 2022 10-Q 2023-11-08
Q2 2022 73.1M +1.32M +1.85% Jun 30, 2022 10-Q 2023-08-08
Q1 2022 71.8M +352K +0.49% Mar 31, 2022 10-Q 2023-05-09
Q4 2021 71.6M +2.41M +3.48% Dec 31, 2021 10-K 2023-02-28
Q3 2021 71.8M +5.25M +7.89% Sep 30, 2021 10-Q 2022-11-08
Q2 2021 71.8M +14.5M +25.3% Jun 30, 2021 10-Q 2022-08-09
Q1 2021 71.4M +14.4M +25.2% Mar 31, 2021 10-Q 2022-05-10
Q4 2020 69.2M +16.8M +32.1% Dec 31, 2020 10-K 2022-02-28
Q3 2020 66.6M +22.5M +51% Sep 30, 2020 10-Q 2021-11-09
Q2 2020 57.3M +13.2M +29.9% Jun 30, 2020 10-Q 2021-08-05
Q1 2020 57M +13M +29.6% Mar 31, 2020 10-Q 2021-05-10
Q4 2019 52.4M +15.4M +41.6% Dec 31, 2019 10-K 2021-02-25
Q3 2019 44.1M +7.12M +19.2% Sep 30, 2019 10-Q 2020-11-09
Q2 2019 44.1M +7.19M +19.5% Jun 30, 2019 10-Q 2020-08-06
Q1 2019 44M +7.26M +19.8% Mar 31, 2019 10-Q 2020-05-07
Q4 2018 37M +459K +1.26% Dec 31, 2018 10-K 2020-02-26
Q3 2018 37M +6.06M +19.6% Sep 30, 2018 10-Q 2019-11-04
Q2 2018 36.9M +6.5M +21.4% Jun 30, 2018 10-Q 2019-08-06
Q1 2018 36.7M +6.61M +22% Mar 31, 2018 10-Q 2019-05-09
Q4 2017 36.5M +7.87M +27.5% Dec 31, 2017 10-K 2019-02-28
Q3 2017 30.9M +2.42M +8.49% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 30.4M +1.93M +6.79% Jun 30, 2017 10-Q 2017-08-04
Q1 2017 30.1M +30.1M Mar 31, 2017 10-Q 2017-05-09
Q4 2016 28.6M +360K +1.27% Dec 31, 2016 10-K 2018-03-02
Q3 2016 28.5M +4.2M +17.3% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 28.5M +4.54M +18.9% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 0 -23.9M -100% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 28.3M +4.51M +19% Dec 31, 2015 10-K 2017-02-28
Q3 2015 24.3M +595K +2.51% Sep 30, 2015 10-Q 2015-11-10
Q2 2015 23.9M +452K +1.93% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 23.9M +5.29M +28.4% Mar 31, 2015 10-Q 2015-05-14
Q4 2014 23.8M +23.5M +9016% Dec 31, 2014 10-K 2016-03-04
Q3 2014 23.7M Sep 30, 2014 10-Q 2014-11-13
Q2 2014 23.5M Jun 30, 2014 10-Q 2014-08-13
Q1 2014 18.7M Mar 31, 2014 10-Q 2014-05-14
Q4 2013 261K Dec 31, 2013 10-K 2015-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.